Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma	Camrelizumab; Locally Advanced Esophageal Squamous Cell Carcinoma; Neoadjuvant Therapy	Recruiting	Phase 2	2026-08-26		NCT07787273

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hefei Cancer Hospital of the Chinese Academy of Sciences	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hefei Cancer Hospital, Chinese Academy of Sciences	Hefei	China	1
The First Affiliated Hospital of Anhui Medical University	Hefei	China	44

Clinical trials